NovoCure (NVCR) Net Income Growth (1y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -11.74% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 99.11% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 4,440.69% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 89.28% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -30.10% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | NovoCure | 1.90 Bn | 1.47 Bn | 135.13 Mn | -107.28% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -107.28% |
| Dec 31, 2025 | 62.84% |
| Sep 30, 2025 | -21.92% |
| Jun 30, 2025 | -20.27% |
| Mar 31, 2025 | 11.46% |
| Dec 31, 2024 | -40.02% |
| Sep 30, 2024 | 38.22% |
| Jun 30, 2024 | 41.87% |
| Mar 31, 2024 | 26.95% |
| Dec 31, 2023 | -26.21% |
| Sep 30, 2023 | -86.20% |
| Jun 30, 2023 | -139.16% |
| Mar 31, 2023 | -1,041.83% |
| Dec 31, 2022 | -40.99% |
| Sep 30, 2022 | -102.50% |
| Jun 30, 2022 | -63.98% |
| Mar 31, 2022 | -12.57% |
| Dec 31, 2021 | -638.09% |
| Sep 30, 2021 | -241.36% |
| Jun 30, 2021 | -984.65% |
| Mar 31, 2021 | -204.45% |
| Dec 31, 2020 | 15.42% |
| Sep 30, 2020 | 381.04% |
| Jun 30, 2020 | 230.31% |
| Mar 31, 2020 | 132.53% |
| Dec 31, 2019 | 127.25% |
| Sep 30, 2019 | 116.50% |
| Jun 30, 2019 | 91.81% |
| Mar 31, 2019 | 41.37% |
| Dec 31, 2018 | -42.81% |
| Sep 30, 2018 | -1.70% |
| Jun 30, 2018 | 26.75% |
| Mar 31, 2018 | -14.85% |
| Dec 31, 2017 | -118.61% |
| Sep 30, 2017 | 65.81% |
| Jun 30, 2017 | 47.86% |
| Mar 31, 2017 | 49.08% |
| Dec 31, 2016 | 278.64% |
| Sep 30, 2016 | -29.22% |
| Jun 30, 2016 | -38.34% |
| Mar 31, 2016 | -52.27% |
| Dec 31, 2015 | -193.10% |
| Sep 30, 2015 | -42.05% |